Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.06%6.62B | 7.90%7.62B | -11.02%2.1B | 6.17%1.96B | 33.48%1.85B | 16.29%1.71B | 13.26%7.06B | 28.75%2.36B | 38.28%1.85B | -27.99%1.38B |
| Cost of revenue | -14.51%5.19B | 9.72%6.07B | 2.76%1.9B | -2.73%1.43B | 46.92%1.49B | 4.18%1.24B | 13.72%5.53B | 33.72%1.85B | 44.68%1.47B | -38.74%1.02B |
| Gross profit | -7.39%1.44B | 1.34%1.55B | -61.51%194.47M | 40.75%531.94M | -3.44%356.87M | 68.21%468.6M | 11.63%1.53B | 13.31%505.31M | 17.99%377.92M | 38.95%369.58M |
| Operating expense | -1.97%895.94M | 3.78%913.93M | -9.43%226.74M | 6.69%241.09M | 12.88%228.51M | 7.80%217.59M | 8.49%880.6M | 13.36%250.35M | 16.03%225.97M | -3.01%202.43M |
| Staff costs | -1.07%535.98M | 5.27%541.77M | 7.57%255.82M | 4.33%95.47M | -2.02%92.48M | 7.80%98.01M | 5.68%514.63M | 4.72%237.83M | 8.89%91.5M | 5.43%94.38M |
| Selling and administrative expenses | 16.31%54.85M | 7.40%47.15M | 43.38%26.55M | -31.27%8.96M | 37.97%6.11M | -30.12%5.54M | 16.92%43.9M | 86.37%18.51M | 35.52%13.03M | -65.26%4.43M |
| -General and administrative expense | 16.31%54.85M | 7.40%47.15M | 43.38%26.55M | -31.27%8.96M | 37.97%6.11M | -30.12%5.54M | 16.92%43.9M | 86.37%18.51M | 35.52%13.03M | -65.26%4.43M |
| Depreciation and amortization | 17.34%30.56M | 20.69%26.05M | ---- | ---- | ---- | ---- | 15.03%21.58M | ---- | ---- | ---- |
| -Depreciation | 17.34%30.56M | 20.69%26.05M | ---- | ---- | ---- | ---- | 15.03%21.58M | ---- | ---- | ---- |
| Rent and land expenses | -2.13%56.38M | 5.42%57.61M | ---- | ---- | ---- | ---- | 3.49%54.65M | ---- | ---- | ---- |
| Other operating expenses | -9.60%218.16M | -1.83%241.34M | -69.40%-139.29M | 12.55%136.66M | 25.38%129.92M | 10.71%114.05M | 14.02%245.84M | 6.32%-82.22M | 20.10%121.43M | -2.66%103.62M |
| Operating profit | -15.15%541.31M | -1.97%637.96M | -112.65%-32.26M | 91.40%290.85M | -23.20%128.36M | 227.18%251.01M | 16.18%650.78M | 13.27%254.96M | 21.03%151.96M | 191.95%167.15M |
| Net non-operating interest income (expenses) | 0.30%-11.05M | 1.89%-11.08M | 17.09%-2.27M | 10.84%-2.57M | -14.08%-3.1M | -6.17%-3.15M | 10.00%-11.3M | 8.47%-2.73M | 5.39%-2.88M | 4.56%-2.72M |
| Non-operating interest income | 250.00%14K | 0.00%4K | -33.33%2K | --0 | ---- | ---- | -87.10%4K | 200.00%3K | --0 | ---- |
| Non-operating interest expense | -0.21%11.07M | -1.88%11.09M | -17.11%2.27M | -10.84%2.57M | 14.11%3.11M | 6.17%3.15M | -10.19%11.3M | -8.40%2.74M | -5.39%2.88M | -5.16%2.72M |
| Net investment income | -15.42%64.21M | 17.83%75.91M | 25.69%3.4M | 47.27%22.42M | -43.27%4.78M | 19.01%45.32M | 40.33%64.43M | -44.09%2.7M | 5.44%15.22M | 339.07%8.42M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -2.41M | 0 | 17.36M | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 58.45%-113M | -818.76%-271.94M | -1,903.88%-261.47M | 93.97%-571K | 65.73%-2.34M | -2,889.72%-7.56M | 69.86%-29.6M | 84.04%-13.05M | -53.60%-9.46M | 56.12%-6.84M |
| Less:Other special charges | -58.26%112.26M | 808.70%268.97M | 1,881.05%258.49M | -93.97%571K | -65.73%2.34M | 2,889.72%7.56M | -69.86%29.6M | -84.04%13.05M | 53.60%9.46M | -56.12%6.84M |
| Less:Write off | -75.33%735K | --2.98M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 38.57%52.87M | -16.32%38.16M | 52.14%31.67M | -78.70%3.81M | 92.29%-41K | -63.36%2.72M | 517.11%45.59M | 431.54%20.82M | 591.14%17.9M | 90.39%-532K |
| Income before tax | 13.42%531.93M | -36.39%469M | -193.17%-260.93M | 81.74%313.95M | -22.86%127.65M | 142.31%288.33M | 52.21%737.26M | 87.83%280.05M | 35.87%172.75M | 370.10%165.47M |
| Income tax | 939.46%168.81M | -112.70%-20.11M | -662.73%-251.34M | 330.00%105.58M | -42.47%35.03M | 221.12%90.63M | 98.19%158.33M | 69.20%44.67M | 28.15%24.55M | 368.00%60.89M |
| Net income | -25.76%363.12M | -15.52%489.11M | -104.07%-9.59M | 40.61%208.37M | -11.44%92.62M | 117.81%197.7M | 43.13%578.93M | 91.84%235.39M | 37.24%148.19M | 371.33%104.58M |
| Net income continuous operations | -25.76%363.12M | -15.52%489.11M | -104.07%-9.59M | 40.61%208.37M | -11.44%92.62M | 117.81%197.7M | 43.13%578.93M | 91.84%235.39M | 37.24%148.19M | 371.33%104.58M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -25.76%363.12M | -15.52%489.11M | -104.07%-9.59M | 40.61%208.37M | -11.44%92.62M | 117.81%197.7M | 43.13%578.93M | 91.84%235.39M | 37.24%148.19M | 371.33%104.58M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.76%363.12M | -15.52%489.11M | -104.07%-9.59M | 40.61%208.37M | -11.44%92.62M | 117.81%197.7M | 43.13%578.93M | 91.84%235.39M | 37.24%148.19M | 371.33%104.58M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.75%277.96 | -15.35%374.37 | -104.08%-7.34 | 40.78%159.5 | -11.32%70.89 | 119.15%151.32 | 49.38%442.26 | 99.21%179.97 | 43.71%113.3 | 393.46%79.94 |
| Diluted earnings per share | -25.75%277.96 | -15.35%374.37 | -104.08%-7.34 | 40.77%159.4944 | -11.32%70.8899 | 119.15%151.32 | 49.38%442.26 | 99.21%179.97 | 43.71%113.3 | 393.46%79.94 |
| Dividend per share | 16.67%70 | 33.33%60 | 33.33%60 | 0 | 0 | 0 | 28.57%45 | 28.57%45 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |